Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8358)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 26, 2020 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xiao BD, Zhao YJ, Jia XY, Wu J, Wang YG, Huang F. Multifaceted p21 in carcinogenesis, stemness of tumor and tumor therapy. World J Stem Cells 2020; 12(6): 481-487 [PMID: 32742565 DOI: 10.4252/wjsc.v12.i6.481] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v12/i6/481.htm |
| Number | Citing Articles |
| 1 |
Hui Zhang, Huixia Zhang, Shengliang Cao, Chao Sui, Yinuo Song, Yiran Zhao, Sidang Liu. Knockout of p53 leads to a significant increase in ALV-J replication. Poultry Science 2021; 100(10): 101374 doi: 10.1016/j.psj.2021.101374
|
| 2 |
Control of Cell Cycle & Cell Proliferation. Advances in Protein Chemistry and Structural Biology 2023; 135: 125 doi: 10.1016/bs.apcsb.2022.11.008
|
| 3 |
Yongye Huang, Ziyan Zhou, Jin Zhang, Zhenzhen Hao, Yunhao He, Zihan Wu, Yiquan Song, Kexun Yuan, Shanyu Zheng, Qi Zhao, Tianye Li, Bing Wang. lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell. Journal of Cellular and Molecular Medicine 2021; 25(15): 7135 doi: 10.1111/jcmm.16742
|
| 4 |
Yan Qiao, Bin Wang, Yu Yan, Ligang Niu. Long noncoding RNA ST8SIA6‐AS1 promotes cell proliferation and metastasis in triple‐negative breast cancer by targeting miR‐145‐5p/CDCA3 to inactivate the p53/p21 signaling pathway. Environmental Toxicology 2022; 37(10): 2398 doi: 10.1002/tox.23605
|
| 5 |
Majji Rambabu, Nagaraj Konageni, Karthick Vasudevan, K R Dasegowda, Anand Gokul, Sivaraman Jayanthi, Karunakaran Rohini. Identification of key biomarkers and associated pathways of pancreatic cancer using integrated transcriptomic and gene network analysis. Saudi Journal of Biological Sciences 2023; 30(11): 103819 doi: 10.1016/j.sjbs.2023.103819
|
| 6 |
Lily Nguyen, Sophie Dobiasch, Günter Schneider, Roland M. Schmid, Omid Azimzadeh, Kristiyan Kanev, Dominik Buschmann, Michael W. Pfaffl, Stefan Bartzsch, Thomas E. Schmid, Daniela Schilling, Stephanie E. Combs. Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer. Radiotherapy and Oncology 2021; 159: 265 doi: 10.1016/j.radonc.2021.03.038
|
| 7 |
Feng Chi, Jason I. Griffiths, Aritro Nath, Andrea H. Bild. Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells. Breast Cancer Research 2024; 26(1) doi: 10.1186/s13058-024-01808-7
|
| 8 |
Wenjing Ma, Yong Cai, Yuntian Shen, Xin Chen, Lilei Zhang, Yanan Ji, Zehao Chen, Jianwei Zhu, Xiaoming Yang, Hualin Sun. HDAC4 Knockdown Alleviates Denervation-Induced Muscle Atrophy by Inhibiting Myogenin-Dependent Atrogene Activation. Frontiers in Cellular Neuroscience 2021; 15 doi: 10.3389/fncel.2021.663384
|
| 9 |
Yeon Hee Park, Seock-Ah Im, Kyunghee Park, Ji Wen, Kyung-Hun Lee, Yoon-La Choi, Won-Chul Lee, Ahrum Min, Vinicius Bonato, Seri Park, Sripad Ram, Dae-Won Lee, Ji-Yeon Kim, Su Kyeong Lee, Won-Woo Lee, Jisook Lee, Miso Kim, Hyun Seon Kim, Scott L. Weinrich, Han Suk Ryu, Tae Yong Kim, Stephen Dann, Yu-Jin Kim, Diane R. Fernandez, Jiwon Koh, Shuoguo Wang, Song Yi Park, Shibing Deng, Eric Powell, Rupesh Kanchi Ravi, Jadwiga Bienkowska, Paul A. Rejto, Woong-Yang Park, Zhengyan Kan. Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer. Genome Medicine 2023; 15(1) doi: 10.1186/s13073-023-01201-7
|
| 10 |
Erika Nallely Orendain-Jaime, Nicolás Serafín-Higuera, Ana Gabriela Leija-Montoya, Gustavo Martínez-Coronilla, Misael Moreno-Trujillo, Fausto Sánchez-Muñoz, Armando Ruiz-Hernández, Javier González-Ramírez. MicroRNAs Encoded by Virus and Small RNAs Encoded by Bacteria Associated with Oncogenic Processes. Processes 2021; 9(12): 2234 doi: 10.3390/pr9122234
|
| 11 |
Wencong Yang, Bingzhi Zhang, Qi Tan, Yan Chen, Tao Chen, Ge Zou, Bing Sun, Bo Wang, Jie Yuan, Zhigang She. 4-Hydroxy-2-pyridone derivatives with antitumor activity produced by mangrove endophytic fungus Talaromyces sp. CY-3. European Journal of Medicinal Chemistry 2024; 269: 116314 doi: 10.1016/j.ejmech.2024.116314
|
| 12 |
Changchun Zhu, Jin Jiang, Guoxing Feng, Saijun Fan. The exciting encounter between lncRNAs and radiosensitivity in IR-induced DNA damage events. Molecular Biology Reports 2023; 50(2): 1829 doi: 10.1007/s11033-022-07966-1
|
| 13 |
Mengmeng Li, Jiaye Yang, Juan Li, Yuan Zhou, Xiaoduo Li, Zhengcai Ma, Xuegang Li, Hang Ma, Xiaoli Ye. Epiberberine induced p53/p21-dependent G2/M cell cycle arrest and cell apoptosis in gastric cancer cells by activating γ-aminobutyric acid receptor- β3. Phytomedicine 2024; 123: 155198 doi: 10.1016/j.phymed.2023.155198
|
| 14 |
Yan Wang, Fuhao Chu, Jie Lin, Yuan Li, Nadia Johnson, Jianglan Zhang, Cong Gai, Zeqi Su, Hongjie Cheng, Linheng Wang, Xia Ding. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification. Journal of Ethnopharmacology 2021; 279: 114399 doi: 10.1016/j.jep.2021.114399
|
| 15 |
Wenke Jin, Jin Zhang, Xiya Chen, Siwen Yin, Haiyang Yu, Feng Gao, Dahong Yao. Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: From underlying mechanisms to targeted therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(4): 188916 doi: 10.1016/j.bbcan.2023.188916
|
| 16 |
Denis L. Jardim, Sherri Z. Millis, Jeffrey S. Ross, Michelle Sue-Ann Woo, Siraj M. Ali, Razelle Kurzrock. Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions. The Oncologist 2021; 26(1): e78 doi: 10.1634/theoncologist.2020-0509
|
| 17 |
Camila Hirakata, Keli Lima, Bruna De Almeida, Lívia De Miranda, Katharine Florêncio, Luciana Furtado, Leticia Costa-Lotufo, João Machado-Neto. Targeting glioma cells by antineoplastic activity of reversine. Oncology Letters 2021; 22(2) doi: 10.3892/ol.2021.12871
|
| 18 |
Igor Y Iskusnykh, Nikolai Fattakhov, Yiran Li, Laure Bihannic, Matthew K Kirchner, Ekaterina Y Steshina, Paul A Northcott, Victor V Chizhikov. Lmx1a is a master regulator of the cortical hem. eLife 2023; 12 doi: 10.7554/eLife.84095
|
| 19 |
Nayane de Oliveira Silva, Luan Vitor Alves de Lima, Liana Martins de Oliveira, Matheus Felipe da Silva, Amanda Passuello de Aguiar, Simone Cristine Semprebon, Phelipe Oliveira Favaron, Sandra Regina Lepri, Ingrid Felicidade, Mario Sergio Mantovani. Cellular and molecular antiproliferative effects in 2D monolayer and 3D-cultivated HT-29 cells treated with zerumbone. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(3): 1561 doi: 10.1007/s00210-023-02701-4
|
| 20 |
Qun Xu, Jinyou Li, Yue Wu, Wenjing Zhou, Zherong Xu. Colorectal Cancer Chemotherapy Drug Bevacizumab May Induce Muscle Atrophy Through CDKN1A and TIMP4. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.897495
|
| 21 |
Duaa Alkaabi, Kholoud Arafat, Shahrazad Sulaiman, Aya Mudhafar Al-Azawi, Samir Attoub. PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression. International Journal of Molecular Sciences 2023; 24(7): 6420 doi: 10.3390/ijms24076420
|
| 22 |
Dan Luo, Chune Yu, Jing Yu, Chao Su, Shun Li, Peng Liang. p53-mediated G1 arrest requires the induction of both p21 and Killin in human colon cancer cells. Cell Cycle 2022; 21(2): 140 doi: 10.1080/15384101.2021.2014249
|
| 23 |
Xiaonuan Luo, Shanshan Chang, Siyu Xiao, Yin Peng, Yuli Gao, Fan Hu, Jianxue Liang, Yidan Xu, Kaining Du, Yang Chen, Jiequan Qin, Stephen J. Meltzer, Shiqi Deng, Xianling Feng, Xinmin Fan, Gangqiang Hou, Zhe Jin, Xiaojing Zhang. PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A. Neoplasia 2022; 33: 100835 doi: 10.1016/j.neo.2022.100835
|
| 24 |
Hai-bin Nong, Ya-nan Zhang, Yi-guang Bai, Qiong Zhang, Ming-fu Liu, Quan Zhou, Zhuo-hua Shi, Gao-feng Zeng, Shao-Hui Zong. Adapalene Inhibits Prostate Cancer Cell Proliferation In Vitro and In Vivo by Inducing DNA Damage, S-phase Cell Cycle Arrest, and Apoptosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.801624
|
| 25 |
Melanie Haas Kucherlapati. Co-expression patterns explain how a basic transcriptional role for MYC modulates Wnt and MAPK pathways in colon and lung adenocarcinomas. Cell Cycle 2022; 21(15): 1619 doi: 10.1080/15384101.2022.2060454
|
| 26 |
Yue Wu, Qin Xiang, Xiaoqin Lv, Xia Xiang, Zhihao Feng, Shaorong Tian, Jun Tang, Tingxiu Xiang, Jianping Gong. C2orf40 inhibits hepatocellular carcinoma through interaction with UBR5. Journal of Gastroenterology and Hepatology 2021; 36(9): 2581 doi: 10.1111/jgh.15441
|
| 27 |
Thomas M. Cardillo, Maria B. Zalath, Roberto Arrojo, Robert M. Sharkey, Serengulam V. Govindan, Chien-Hsing Chang, David M. Goldenberg. Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas. Oncotarget 2024; 15(1): 144 doi: 10.18632/oncotarget.28559
|
| 28 |
Qi Wang, Wei Zhang, Dandan Yin, Zaibin Tang, Erbao Zhang, Weibing Wu. Gene amplification-driven lncRNA SNHG6 promotes tumorigenesis via epigenetically suppressing p27 expression and regulating cell cycle in non–small cell lung cancer. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-01276-y
|
| 29 |
Dan Zhu, Xiaojian Li, Yu Zhu, Qingyun Wei, Yang Hu, Shao Su, Jie Chao, Lianhui Wang, Lixing Weng. Spatiotemporal Monitoring of Subcellular mRNAs In Situ via Polyadenine-Mediated Dual-Color Sticky Flares. ACS Applied Materials & Interfaces 2023; 15(12): 15250 doi: 10.1021/acsami.3c01242
|
| 30 |
Bella M. Ben-Oz, Feras E. Machour, Marian Nicola, Amir Argoetti, Galia Polyak, Rawad Hanna, Oded Kleifeld, Yael Mandel-Gutfreund, Nabieh Ayoub. A dual role of RBM42 in modulating splicing and translation of CDKN1A/p21 during DNA damage response. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-43495-6
|
| 31 |
In-Youb Chang, Sang-Pil Yoon. Increased soluble E‑cadherin of spheroid formation supplemented with fetal bovine serum in colorectal cancer cells. Oncology Letters 2023; 25(5) doi: 10.3892/ol.2023.13793
|
| 32 |
Xiaoyan Ren, Gaoshan Zhang, Xiang Ling, Linhua Zhang, Yangyang Tian, Guoxiang Zhu, Pengbo Wang, Jianmei W. Leavenworth, Lin Luo, Fengzhi Li. Allyl-isothiocyanate against colorectal cancer via the mutual dependent regulation of p21 and Nrf2. European Journal of Pharmacology 2023; 957: 176016 doi: 10.1016/j.ejphar.2023.176016
|
| 33 |
Evangelos Manousakis, Clàudia Martinez Miralles, Maria Guimerà Esquerda, Roni H. G. Wright. CDKN1A/p21 in Breast Cancer: Part of the Problem, or Part of the Solution?. International Journal of Molecular Sciences 2023; 24(24): 17488 doi: 10.3390/ijms242417488
|
| 34 |
Farzad Rahmani, Mehrdad Zandigohar, Pegah Safavi, Maryam Behzadi, Zeynab Ghorbani, Mahya Payazdan, Gordon Ferns, Seyed Mahdi Hassanian, Amir Avan. The Interplay between Noncoding RNAs and p21 Signaling in Gastrointestinal
Cancer: From Tumorigenesis to Metastasis. Current Pharmaceutical Design 2023; 29(10): 766 doi: 10.2174/1381612829666230306123455
|
| 35 |
Wei Zhou, Weiyang Lou, Junru Chen, Bisha Ding, Binjie Chen, Haiyang Xie, Lin Zhou, Shusen Zheng, Donghai Jiang. AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest. OncoTargets and Therapy 2021; : 1049 doi: 10.2147/OTT.S289324
|
| 36 |
Samayaditya Singh, Manjari Kiran, Pramod R. Somvanshi. Reverse Engineering of Regulatory Networks. Methods in Molecular Biology 2024; 2719: 295 doi: 10.1007/978-1-0716-3461-5_16
|
| 37 |
NiloofarTaleghani Seyedabadi, Sara YousefZadeh Shoushtari, Asma Soofi, Javad Arabpour, Zinat Shams, Homa Akhavan, Saied Hosseini-Asl. Molecular profiles of predictive biomarkers for platinum-based chemotherapy in Non-Small Cell Lung Cancer (NSCLC). Meta Gene 2022; 31: 100993 doi: 10.1016/j.mgene.2021.100993
|
| 38 |
Tingting Zhao, Fengqi Dong, Xinlong Hu, Yanli Xu, Wenmei Wei, Rui Liu, Fang Yu, Weijun Fang, Yuxian Shen, Zhongping Zhang. Dynamic tracking of p21 mRNA in living cells by sticky-flares for the visual evaluation of the tumor treatment effect. Nanoscale 2022; 14(5): 1733 doi: 10.1039/D1NR05418J
|
| 39 |
Martina Zigová, Viktória Miškufová, Marianna Budovská, Radka Michalková, Ján Mojžiš. Exploring the Antiproliferative and Modulatory Effects of 1-Methoxyisobrassinin on Ovarian Cancer Cells: Insights into Cell Cycle Regulation, Apoptosis, Autophagy, and Its Interactions with NAC. Molecules 2024; 29(8): 1773 doi: 10.3390/molecules29081773
|
| 40 |
Candida Fasano, Martina Lepore Signorile, Katia De Marco, Giovanna Forte, Paola Sanese, Valentina Grossi, Cristiano Simone. Identifying novel SMYD3 interactors on the trail of cancer hallmarks. Computational and Structural Biotechnology Journal 2022; 20: 1860 doi: 10.1016/j.csbj.2022.03.037
|
| 41 |
Varun Jaiswal, Hae-Jeung Lee. Pharmacological Activities of Mogrol: Potential Phytochemical against Different Diseases. Life 2023; 13(2): 555 doi: 10.3390/life13020555
|
| 42 |
Yongxiu Du, Yanlan Yang, Wenbo Zhang, Chenxi Yang, Pu Xu. Human β-defensin-3 and nuclear factor-kappa B p65 synergistically promote the cell proliferation and invasion of oral squamous cell carcinoma. Translational Oncology 2023; 27: 101582 doi: 10.1016/j.tranon.2022.101582
|